Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • +1 (905) 565-9495 Request Information
  • French

Igenomix at ASRM 2022

Thank you for joining Igenomix and Vitrolife at this year’s ASRM 2022 Scientific Congress & Expo in Anaheim, California. We hope you had the opportunity to learn more about our innovative new research and attend one of our LIVE studio sessions. If you were unable to join us, click on the button below for access to our studio sessions and more. 

Click Here for Igenomix at ASRM

 

2022 PGT-A Webinar Series

View our PGT-A webinar series recordings. Click below to access the individual presentation recording links.

View Recordings

Endometrial microbiota is associated with reproductive outcome in infertile patient

New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatments strategies

 

Learn more!

Vitrolife completes THE acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.

Visit Vitrolife website

Vitrolife completes the acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey

Visit Vitrolife website

500
SCIENTIFIC
PUBLICATIONS

20
LABS
WORLDWIDE

++600
PROFESSIONALS

+4
PATENTS

Genetic Solutions for Specialists

Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.

Preconception

Detect genetic changes in the egg source or sperm source before conception so you can explore about options to have a healthy baby

More information

Preimplantation

Help reduce the risk for implantation failure or miscarriage and improve the chances for a healthy pregnancy

More information

Prenatal

Understand whether a pregnancy is at an increased risk for a genetic syndrome

More information
See all services

We will guide you

Fertility

Educational content whatever is your reproductive journey

More information

Healthy Pregnancy

Avoid a miscarriage or an implantation failure

More information

Your Baby

Maximize your chances during an IVF treatment

More information
See all services

Igenomix Research

Igenomix Development

We actively works in research the most advanced techniques to reproductive genetics.

Igenomix Research

Providing solutions to professionals working in reproductive medicine

About Igenomix

Igenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011. 

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide, we investigate human reproduction to change the lives of couples who are trying to conceive. 

In 2021, Vitrolife acquired Igenomix. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. 

Learn more about Igenomix

Corporate news

Prof. Simon joins the debate about mosaicism in The Wall Street Journal
More news

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics

ABOUT US

About Igenomix
Contact
Press and news
Quality
Work with us

FOLLOW IGENOMIX

Blog: Road to fertility

*CAP accreditation applies to the LA lab.

  +1 (905) 565-9495  fax +1 (905) 671-1938
  Email us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Language

[2019] © Igenomix Privacy policy Quality policy Terms & conditions User Feedback

Request Information


  • reCAPTCHA demo: Simple page

  • We guide you
    • Fertility
    • Healthy Pregnancy
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • EMBRACE
      • PGT-M
      • NACE
      • POC
      • SAT
  • Kit Request
  • About us
    • Igenomix Research
    • About Igenomix
  • Academy
  • Webinars
  • Blog
  • French
  • Canada